Navigation Links
ResearchDx Launches Contract Diagnostics Organization (CDO)
Date:2/22/2011

IRVINE, Calif., Feb. 22, 2011 /PRNewswire/ -- ResearchDx announced today the official launch of the first-ever Contract Diagnostics Organization or CDO.

Recent FDA initiatives, such as the Critical Path Initiative and the Drug-Diagnostic Co-Development Concept Paper, have spurred biopharmaceutical companies' interest in biomarker research for the purpose of developing companion diagnostics. The traditional Contract Research Organization (CRO), which has focused on clinical trials for pharmaceutical products, cannot meet the need for both an in-depth knowledge of the diagnostics industry and the ability to run diagnostic tests in a clinical laboratory. Conversely, Diagnostics companies lack the ability to perform clinical testing and have an incentive to steer diagnostic development toward their existing products' technology platforms. However, ResearchDx, as a CDO, provides all of these services in an integrated, technology-independent manner that stays focused on their customers' business objectives.

"At ResearchDx, we take contract R&D for diagnostics to the next generation," states co-founder Philip Cotter.  "Our partners trust ResearchDx to provide everything they need to develop a diagnostic product, and that we make their business objectives our priority."

Dr. Philip Cotter and Dr. Mat Moore, the founders of ResearchDx, have a passion for the advancement of personalized medicine. With their team's extensive experience in managing clinical laboratories, designing and managing clinical research, and navigating the complex regulatory environment specific to diagnostics, they saw the opportunity to fill an unmet need for partnership with the biopharmaceutical and diagnostics industries.  In founding the first-ever CDO, they have achieved their vision to help biopharmaceutical companies overcome the barriers to developing diagnostic products.

About ResearchDx

ResearchDx is a Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides integrated, flexible services for the diagnostic development process – from initial assay concepts and discovery through clinical research to regulatory approval.   ResearchDx's service areas include clinical research, clinical laboratory services, diagnostic manufacturing, and consulting.

CONTACT:  Philip Cotter, +1-510-332-0477, for ResearchDx


'/>"/>
SOURCE ResearchDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PreXion Launches New Faster, Lower Radiation PreXion3D Elite Cone Beam Imaging System
2. Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System
3. Success Factors and Failure Points in Biopharmaceutical Product Launches
4. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
5. HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad
6. Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
7. Brainlab Launches Refreshed Website
8. Cayenne Medical, Inc. Launches AperFix® II
9. ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
10. Mylan Launches First Generic Version of Vfend® Tablets
11. PARI Respiratory Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/12/2017)... Canada joint tech company Laughing Face has developed ... and features a powerful disinfection process. The company has ... and sanitizes women,s panties or babies, cloth diapers in 25 minutes. ... Laughing ... external water inlet. ...
Breaking Medicine Technology:
(Date:5/29/2017)... PA (PRWEB) , ... May 29, 2017 , ... The ... simple question: How do doctors determine if someone is cured? The virus has a ... most expensive and time-consuming tests. , Scientists at the University of Pittsburgh’s Graduate School ...
(Date:5/28/2017)... ... ... Viewers likely know Rob Lowe from such 80s hits as St. Elmo’s Fire ... NBC’s The West Wing and Parks and Recreation. But recently, Lowe’s leant his talents ... spotlight on important modern-day issues that face today’s society. One of the most recent ...
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar ... a new study from the Osteoarthritis Initiative shows that certain people who ... Knowing this in advance may give doctors the opportunity to treat patients before the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is the first physician in ... cord stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a ... first in Arkansas to introduce the most powerful SCS system and the only stretchable ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) ... House on May 4, would result in 23 million Americans losing their health insurance ... 2010 Patient Protection and Affordable Care Act (ACA). , “It is clear from ...
Breaking Medicine News(10 mins):